161 related articles for article (PubMed ID: 27855375)
41. Three circulating long non-coding RNAs act as biomarkers for predicting NSCLC.
Tang Q; Ni Z; Cheng Z; Xu J; Yu H; Yin P
Cell Physiol Biochem; 2015; 37(3):1002-9. PubMed ID: 26393913
[TBL] [Abstract][Full Text] [Related]
42. Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer.
Zhang Y; Jin X; Wang Z; Zhang X; Liu S; Liu G
Cancer Biomark; 2017 Dec; 21(1):89-96. PubMed ID: 29081407
[TBL] [Abstract][Full Text] [Related]
43. Long non-coding RNA-Low Expression in Tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expression.
Wang PL; Liu B; Xia Y; Pan CF; Ma T; Chen YJ
Mol Med Rep; 2016 Apr; 13(4):3074-82. PubMed ID: 26935396
[TBL] [Abstract][Full Text] [Related]
44. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis.
Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K
Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022
[TBL] [Abstract][Full Text] [Related]
45. High TUG1 expression is associated with chemotherapy resistance and poor prognosis in esophageal squamous cell carcinoma.
Jiang L; Wang W; Li G; Sun C; Ren Z; Sheng H; Gao H; Wang C; Yu H
Cancer Chemother Pharmacol; 2016 Aug; 78(2):333-9. PubMed ID: 27329359
[TBL] [Abstract][Full Text] [Related]
46. Long non-coding RNA 91H contributes to the occurrence and progression of esophageal squamous cell carcinoma by inhibiting IGF2 expression.
Gao T; He B; Pan Y; Xu Y; Li R; Deng Q; Sun H; Wang S
Mol Carcinog; 2015 May; 54(5):359-67. PubMed ID: 24706416
[TBL] [Abstract][Full Text] [Related]
47. Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer.
Dong Z; Zhang A; Liu S; Lu F; Guo Y; Zhang G; Xu F; Shi Y; Shen S; Liang J; Guo W
Mol Cancer Res; 2017 Jul; 15(7):800-810. PubMed ID: 28539329
[TBL] [Abstract][Full Text] [Related]
48. Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma.
Zang W; Wang T; Wang Y; Chen X; Du Y; Sun Q; Li M; Dong Z; Zhao G
Oncotarget; 2016 Apr; 7(15):19960-74. PubMed ID: 26799587
[TBL] [Abstract][Full Text] [Related]
49. Circulating LncRNAs Serve as Diagnostic Markers for Hepatocellular Carcinoma.
Yuan W; Sun Y; Liu L; Zhou B; Wang S; Gu D
Cell Physiol Biochem; 2017; 44(1):125-132. PubMed ID: 29130980
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma.
Liao Y; Xing S; Xu B; Liu W; Zhang G
Oncotarget; 2017 May; 8(18):30050-30062. PubMed ID: 28415791
[TBL] [Abstract][Full Text] [Related]
51. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
Cui Y; Xue Y; Dong S; Zhang P
J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
[TBL] [Abstract][Full Text] [Related]
52. Copy number loss of variation_91720 in PIK3CA predicts risk of esophageal squamous cell carcinoma.
Wu Y; Liu X; Hu L; Tao H; Guan X; Zhang K; Bai Y; Yang K
Int J Clin Exp Pathol; 2015; 8(11):14479-85. PubMed ID: 26823766
[TBL] [Abstract][Full Text] [Related]
53. The global expression profiling in esophageal squamous cell carcinoma.
Dai F; Mei L; Meng S; Ma Z; Guo W; Zhou J; Zhang J
Genomics; 2017 Jul; 109(3-4):241-250. PubMed ID: 28442363
[TBL] [Abstract][Full Text] [Related]
54. LncRNA GHET1 promotes esophageal squamous cell carcinoma cells proliferation and invasion via induction of EMT.
Liu H; Zhen Q; Fan Y
Int J Biol Markers; 2017 Oct; 32(4):e403-e408. PubMed ID: 28983895
[TBL] [Abstract][Full Text] [Related]
55. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition.
Zhang CY; Li RK; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
Cell Biol Toxicol; 2016 Oct; 32(5):391-401. PubMed ID: 27250657
[TBL] [Abstract][Full Text] [Related]
56. Pseudogene PHBP1 promotes esophageal squamous cell carcinoma proliferation by increasing its cognate gene PHB expression.
Feng F; Qiu B; Zang R; Song P; Gao S
Oncotarget; 2017 Apr; 8(17):29091-29100. PubMed ID: 28404970
[TBL] [Abstract][Full Text] [Related]
57. [Expression level and clinical significance of LncRNA HOXA11-AS in esophageal squamous cell carcinoma patients].
Sun XY; Wang XF; Cui YB; Cao XG; Zhao RH; Wei HY; Cao W; Wu W
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):186-190. PubMed ID: 29575836
[No Abstract] [Full Text] [Related]
58. Down-regulation of lncRNA MIR31HG correlated with aggressive clinicopathological features and unfavorable prognosis in esophageal squamous cell carcinoma.
Ren ZP; Chu XY; Xue ZQ; Zhang LB; Wen JX; Deng JQ; Hou XB
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3866-3870. PubMed ID: 28975978
[TBL] [Abstract][Full Text] [Related]
59. Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay.
Jia K; Li W; Wang F; Qu H; Qiao Y; Zhou L; Sun Y; Ma Q; Zhao X
Oncotarget; 2016 Apr; 7(17):23569-80. PubMed ID: 26993605
[TBL] [Abstract][Full Text] [Related]
60. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ
Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]